Articles tagged with Protein Folding
Researchers have created self-assembling protein-mimics that can selectivity transport water across membranes while rejecting salts, offering a potential solution to improve energy efficiency in industrial water purification. The oligourea foldamers are smaller and more stable than existing artificial water channels.
A new study reveals that the cellular chaperone protein GRP78 migrates to the nucleus under stress and alters gene activities, allowing cancer cells to become more mobile and invasive. This discovery offers potential new approaches for cancer treatment, including down-regulating GRP78 activity or preventing it from binding to ID2.
Researchers developed a new high-throughput approach to evaluate protein folding stability, identifying factors contributing to stability and informing predictive models. The cDNA display proteolysis method permits large-scale analysis of nearly 900,000 proteins, shedding light on diseases involving misfolded proteins.
Researchers identify at least 10,000 novel foldable αβ-folds, expanding our understanding of the protein universe. The discovery has significant implications for fields like drug development and enzyme design.
Researchers discovered that extracellular cytochrome nanowires are widespread in prokaryotic microbes, including both bacteria and archaea. The findings suggest that these nanowires, composed of a long chain of cytochrome proteins, play a crucial role in microbial metabolism by facilitating efficient electron transfer.
Researchers found that a mutation in RPL3L, expressed only in heart and skeletal muscle, leads to impaired cardiac contractility by causing ribosomal collisions and protein folding abnormalities. The study aims to develop new treatments for cardiomyopathy and atrial fibrillation.
Researchers have developed a system that uses generative diffusion to create new proteins, advancing the field of generative biology. The system, called ProteinSGM, learns from image representations to generate fully new proteins, which are biophysically real and functional.
A new study at Stanford University found a previously unknown cellular pathway for clearing misfolded proteins from the nucleus. This pathway could be a target for therapies of age-related diseases like Alzheimer's, Parkinson's, and Huntington's. Cells use this pathway to manage misfolded proteins in both the cytoplasm and nucleus.
Scientists at UvA have created a new, highly improved bright red fluorescent protein called mScarlet3. This variant combines maximum brightness with fast and complete folding, making it an ideal tool for researchers studying cellular processes.
Researchers found that specific amino acids were essential for the evolution of ancient proteins, which then shaped the genetic code of microorganisms. This discovery sheds light on the mystery of how life began on Earth and has implications for understanding evolution and potentially finding life beyond our planet.
A team from Australian National University has modified the protein folding properties of bacteria by adding multiple components from plant chloroplasts. This enables them to study and speed up plant Rubisco, a slow protein that requires 'chaperones' for operation.
Researchers at Rice University have discovered a new way protein structures communicate with each other to regulate hormone activity. This finding could lead to improved therapies for breast cancer and other diseases.
A new laboratory test can measure levels of amyloid beta oligomers in blood samples, detecting toxic proteins up to years before cognitive impairment. The test, SOBA, has shown promising results in identifying individuals at risk or incubating Alzheimer's disease.
A team of researchers from the University of Pennsylvania has developed a new algorithm, metadynamics, that can navigate high-dimensional energy landscapes to find low-energy configurations. This breakthrough has the potential to revolutionize fields such as protein folding and machine learning.
A study at the University of Gothenburg discovered a unique quick-closing valve in the aquaporins of climbing perch fish, allowing them to rapidly regulate water in their cells. This finding could lead to the development of new drugs for cancer and Alzheimer's disease by understanding how brain cell aquaporins function.
Researchers at University of Cambridge found that a thin shell of water surrounding proteins can determine aggregation, with slower movement leading to more clumping. The discovery has significant implications for treating protein misfolding diseases like Parkinson's and Alzheimer's.
The AlphaFold2 AI model has contributed 25% more high-quality protein structures to existing species, aiding in understanding protein function and designing targeted drugs for cancer. Despite limitations, its impact will transform life sciences with new computational tools.
Researchers developed a new software tool called ProteinMPNN to create protein molecules more accurately and quickly than before. The team used machine learning algorithms, including AlphaFold, to generate new protein shapes and sequences, paving the way for novel vaccines, treatments, and sustainable biomaterials.
A research team led by Prof. Dr. Birte Höcker applied a computer-based natural language processing model to protein research, creating new proteins capable of stable folding and defined functions. The ProtGPT2 model generates proteins with differentiated structures, eliminating the need for functionalization processes.
A team of researchers from UMass Amherst and UMass Chan Medical School has developed a technique to increase the secretion of alpha-1 antitrypsin (AAT) in muscle cells by about 50 percent. This breakthrough will help improve gene therapies for diseases caused by dysfunctional protein production.
Researchers found reduced levels of Histone Deacetylase I (HDAC I) in the brains of patients with Alzheimer's disease, linked to deleterious effects of misfolded beta-amyloid and tau proteins. HDAC inhibitors, currently being tested against mild Alzheimer's disease, may be harming patients rather than helping them.
Scientists use a unique tool to apply mechanical forces that affect protein folding, revealing talin's interaction with tumor-suppressing protein DCL1. This discovery provides insight into the antitumor effect of DCL1 and potential new treatments for metastatic cancer.
A Tokyo University of Science study found that fluoride nanoparticles enhance β-sheet formation in amyloid β proteins, a common feature of Alzheimer's disease. The researchers also discovered that surrounding ions can control this process, paving the way for targeted treatments.
Researchers from Johannes Gutenberg University Mainz used AlphaFold to predict the structures of new protein knots, discovering the most complex knot and composite knots. These findings provide insight into folding mechanisms and evolutionary processes in proteins.
Researchers discovered a mechanism by which plants stabilize protein molecules during folding, even in low-oxygen conditions. The study found that the redox potential of supporting proteins plays a critical role in disulfide bridge formation and protein folding.
Researchers at the University of New Hampshire have found that a repurposed drug compound can inhibit the activity of SARS-CoV-2's main protease enzyme. This breakthrough could lead to new treatments and slow the spread of COVID-19, an RNA virus known for causing seasonal epidemics.
Researchers have developed a new probe to detect Alzheimer's disease biomarkers using near-infrared fluorescence, which may help diagnose the disease early and prevent its progression. The probe binds oligomeric Aβ proteins, a hallmark of Alzheimer's disease, offering a potential alternative to existing treatments.
Scientists found a connection between the SARS-CoV-2 virus and the production of misfolded proteins called amyloids, which can cause complex symptoms and damage in organs such as the heart and kidneys. The researchers' discovery may help explain why COVID-19 often affects multiple parts of the body.
Researchers have developed a new NMR method to monitor fast biomolecular events like protein folding, enabled by hyperpolarized water. This technique enhances signal intensities by up to 10,000-fold, allowing for real-time monitoring and tracking of individual amino acids.
Researchers at Arizona State University have designed and constructed artificial membrane channels using DNA, allowing selective transport of ions, proteins, and cargo. The channels can be opened and closed with a lock and key mechanism, enabling diverse scientific domains such as biosensing and drug delivery applications.
Researchers at the University of Cambridge have identified a new mechanism that appears to reverse the build-up of aggregates in neurodegenerative diseases, such as Alzheimer's and Parkinson's. By stressing cells, they found that protein misfolding was eliminated, potentially allowing for the refolding of correctly folded proteins.
Chelsea Vickers' paper analyzed the 'enzymatic dark matter' in enzymology, revealing a limited number of biochemically characterized enzymes from certain species and phyla. Ryan Woloschuk's paper designed a photoswitchable binding protein using the Z domain, showcasing its potential applications.
Researchers create complex mixtures of biomolecules that spontaneously form self-organized patterns in response to environmental changes. This breakthrough bridges the complexity gap between chemistry and biology.
A new study identifies the age-dependent formation of TMEM106B amyloid filaments in human brains, which may not be linked to neurodegenerative diseases. Researchers found these protein structures in older but not younger individuals, suggesting a potential role in aging and other pathologies.
Researchers at the University of Texas at Austin found a new approach to impairing antibiotic resistance in deadly bacteria by inhibiting the protein DsbA. This method could potentially restore the effectiveness of existing antibiotics, addressing a global health crisis responsible for millions of deaths annually.
Researchers found that mitochondria can respire away harmful substances to protect protein folding, revealing an unexpected 'patron saint' role. This mechanism is triggered by reductive stress and protects proteins destined for export, showcasing the flexibility of plant mitochondria.
A new study reveals that drugs commonly used to treat cystic fibrosis work by aiding protein folding, binding CFTR to ensure proper configuration. This finding may lead to the development of novel medications for diseases caused by misfolded proteins.
Aging leads to protein misfolding, which overwhelms the cell's quality control system. Ribosome dysfunction causes a snowball effect of dysfunction, leading to disease. Insights from yeast and roundworm models suggest a two-pronged situation where aging increases stalling and collisions, but the safety net is lost.
Scientists have successfully engineered protein needles that can self-assemble into lattice structures and ordered monomeric states. The study's findings provide insights into protein-protein interactions and could lead to the development of biocompatible materials and targeted drug transports.
Scientists have identified a crucial mechanism for Rhodopsin production in fruit flies, which may lead to a better understanding of retinitis pigmentosa and vision loss. The study reveals that the EMC protein complex is essential for the proper folding and insertion of Xport-A, a key chaperone of Rhodopsin.
A research team at Aarhus University has developed an RNA aptamer that attaches to the surface of SARS-CoV-2 virus particles, preventing it from entering human cells. This molecule is cheaper and easier to manufacture than current antibodies, making it a promising tool for detecting covid-19 infection.
A team of researchers, including those from Rensselaer Polytechnic Institute and the University of Washington, have developed a neural network that can predict protein shapes with high accuracy. The network was trained on random protein sequences and generated 2,000 new proteins, many of which were successfully produced in the lab.
A team of scientists has created a neural network that can predict and generate new protein structures using deep learning. The network, trained on random protein sequences, can produce stable protein shapes with remarkable accuracy.
Researchers found two prion gene variants in Père David's deer that may reduce susceptibility to CWD. The genetic variants were surprising given the population's small founder size and conserved prion protein gene. Studies are needed to confirm whether these variants provide protection against CWD.
A study led by New York University researchers found that the FDA-approved hepatitis C treatment telaprevir can increase bacterial sensitivity to antibiotics and reduce antibiotic resistance. The antiviral blocks the function of essential proteins in bacteria, revealing an opportunity to repurpose the drug to use alongside antibiotics.
A team of scientists has identified a compound that shows promise in easing COVID-19 symptoms by targeting the cellular quality-control system damaged by coronaviruses. The compound, AMG PERK 44, was found to halt virus replication and boost lung function in mice infected with MERS.
Researchers at UMass Amherst discovered that molecular chaperones display 'selective promiscuity', enabling them to play a crucial role in maintaining healthy cells. This property allows chaperones to help many different proteins, which is essential for cell health.
A new algorithm developed by Carnegie Mellon University researchers offers a powerful tool for illustrating genome folding in cell nuclei. The Higashi algorithm analyzes chromatin interactions using single-cell Hi-C technology, revealing detailed variations in genome organization from cell to cell.
A new study by Okayama University scientists shows that proteins' hydrophobic parts do not repel water as previously thought. The researchers used computational methods to find that the van der Waals force between hydrophobic parts stabilizes the unfolded structure, leading to folding.
Researchers discovered that amyloid beta peptides, which form gummy plaques in Alzheimer's disease, go through several intermediate stages of frustration as they dock and lock to growing fibrils. This suggests that drugs might be developed to stabilize the fibril tips and block further aggregation by targeting the 'Achilles' heel' of f...
Silent mutations, which don't change protein sequences, hold diagnostic value in predicting cancer types and patient survival. The study analyzed over 10,000 cancer genomes and found that combining information from silent and non-silent mutations improved classification and prognostication up to 17% and 5%, respectively.
Researchers at Penn Medicine discovered that restoring DAXX protein levels can prevent the misfolding of proteins associated with Alzheimer's disease and certain cancers. This finding could lead to new targeted approaches for treating these diseases, including reducing neurodegeneration and tumor growth.
Scientists developed a new mouse line to study protein balance and quality control in the mammalian brain. The research revealed that different neurodegenerative diseases have distinct protein misfolding patterns, offering insights into potential therapeutic options.
Scientists at the University of Groningen discovered how a folding protein cytochrome c interacts with mitochondria, leading to programmed cell death. The study found that cytochrome c is partly unfolded during this process, allowing for the regulation of cell death through drug development.
Scientists at the University of Leeds have developed an approach to control the structure and mechanics of synthetic biomaterials made from proteins. By removing specific chemical bonds, known as 'protein staples,' they altered the structure of a protein network, resulting in different mechanical properties.
Researchers at Keck School of Medicine of USC have identified GRP78 as a molecular chaperone that plays a crucial role in the spread of SARS-CoV-2, offering a potential new therapy to combat COVID-19. Targeting GRP78 with therapies could provide additional protection against COVID-19 and its variants.
Researchers create system to sense unusual DNA folds using chemical receptors, which could silence genes linked to cancer or promote tumor growth. The technology has potential applications in disease research and gene regulation.
Researchers at Tokyo Institute of Technology discover that hydrostatic pressure can dynamically control the conformations of artificial molecules called foldamers, which mimic proteins. This finding opens doors to future development of pressure-sensitive materials and has implications for understanding biological processes.
A new mouse model study by USF Health researchers reveals that chaperone protein imbalance can initiate toxic tau accumulation in the aging brain, a key step in Alzheimer's disease development. The study aims to identify therapeutic targets by restoring chaperone protein balance.
Researchers found that the genetic foundation required for oral venom to evolve is present in both reptiles and mammals. Salivary gland tissues in mammals display a similar pattern of gene activity as snake venom glands, suggesting an ancient functional core shared since the two lineages split hundreds of millions of years ago.